Full cohort | Index HbA1c ≥ 7 | ||
---|---|---|---|
Covariate | Comparison | Hazard Ratio (CI) | Hazard Ratio* (CI) |
Age | 18–24 years | Ref | Ref |
25–34 years | 2.05(1.77–2.38) | 2.11(1.81–2.45) | |
35–44 years | 1.41(1.22–1.63) | 1.45(1.25–1.68) | |
45–54 years | 1.02(0.89–1.18) | 1.03(0.89–1.19) | |
55–64 years | 1.04(0.91–1.2) | 1.05(0.91–1.21) | |
65 + years | 1.29(1.12–1.48) | 1.32(1.14–1.52) | |
Sex | Female | Ref | Ref |
Male | 1.33(1.29–1.38) | 1.28(1.23–1.33) | |
Adherence | Low | Ref | Ref |
Moderate | 2.72(2.61–2.83) | 2.7(2.58–2.82) | |
High | 7.82(7.28–8.4) | 7.49(6.96–8.07) | |
Index HbA1c (%) | 7–8% | Ref | Ref |
< 7% | 1.02(0.96–1.08) | - | |
8–9% | 0.41(0.39–0.43) | 0.41(0.39–0.43) | |
9–10% | 0.27(0.25–0.28) | 0.27(0.25–0.29) | |
10–12% | 0.21(0.2–0.22) | 0.22(0.21–0.23) | |
> 12% | 0.23(0.22–0.24) | 0.24(0.22–0.25) |